Matches in Nanopublications for { <http://www.nextprot.org/nanopubs#NX_Q9UKM7-1_MUTAGEN_599_599.RA-H_-LXi2MQWvUXeM6AUF7p-EF7xExUd9TkuFC2u0lfs._1> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NX_Q9UKM7-1_MUTAGEN_599_599.RA-H_-LXi2MQWvUXeM6AUF7p-EF7xExUd9TkuFC2u0lfs._1 type RangedSequencePosition NX_Q9UKM7-1_MUTAGEN_599_599.RA-H_-LXi2MQWvUXeM6AUF7p-EF7xExUd9TkuFC2u0lfs.assertion.
- NX_Q9UKM7-1_MUTAGEN_599_599.RA-H_-LXi2MQWvUXeM6AUF7p-EF7xExUd9TkuFC2u0lfs._1 type SO_0001148 NX_Q9UKM7-1_MUTAGEN_599_599.RA-H_-LXi2MQWvUXeM6AUF7p-EF7xExUd9TkuFC2u0lfs.assertion.
- NX_Q9UKM7-1_MUTAGEN_599_599.RA-H_-LXi2MQWvUXeM6AUF7p-EF7xExUd9TkuFC2u0lfs._1 comment "Very significant reduction in K(cat), 4-fold weaker binding affinity for Man(9)GlcnAc(2) but about 1000-fold reduction in binding affinity for the inhibitor, dMNJ. Significant reductions in K(cat) and slight increase in K(m); when associated with E-330 or N-463." NX_Q9UKM7-1_MUTAGEN_599_599.RA-H_-LXi2MQWvUXeM6AUF7p-EF7xExUd9TkuFC2u0lfs.assertion.
- NX_Q9UKM7-1_MUTAGEN_599_599.RA-H_-LXi2MQWvUXeM6AUF7p-EF7xExUd9TkuFC2u0lfs._1 SIO_000053 NX_Q9UKM7-1_MUTAGEN_599_599.RA-H_-LXi2MQWvUXeM6AUF7p-EF7xExUd9TkuFC2u0lfs._2 NX_Q9UKM7-1_MUTAGEN_599_599.RA-H_-LXi2MQWvUXeM6AUF7p-EF7xExUd9TkuFC2u0lfs.assertion.
- NX_Q9UKM7-1_MUTAGEN_599_599.RA-H_-LXi2MQWvUXeM6AUF7p-EF7xExUd9TkuFC2u0lfs._1 SIO_000053 NX_Q9UKM7-1_MUTAGEN_599_599.RA-H_-LXi2MQWvUXeM6AUF7p-EF7xExUd9TkuFC2u0lfs._3 NX_Q9UKM7-1_MUTAGEN_599_599.RA-H_-LXi2MQWvUXeM6AUF7p-EF7xExUd9TkuFC2u0lfs.assertion.